Gene-gene interaction and RNA splicing profiles of MAP2K4 gene in rheumatoid arthritis.

We performed gene-gene interaction analysis, with HLA-DRB1 shared epitope (SE) alleles for 195 SNPs within immunologically important MAP2K, MAP3K and MAP4K gene families, in 2010 rheumatoid arthritis (RA) patients and 2280 healthy controls. We found a significant statistical interaction for rs10468473 with SE alleles in autoantibody-positive RA. Individuals heterozygous for rs10468473 demonstrated higher expression of total MAP2K4 mRNA in blood, compared to A-allele homozygous. We discovered a novel, putatively translated, "cassette exon" RNA splice form of MAP2K4, differentially expressed in peripheral blood mononuclear cells from 88 RA cases and controls. Within the group of RA patients, we observed a correlation of MAP2K4 isoform expression with carried SE alleles, autoantibody, and rheumatoid factor profiles. TNF-dependent modulation of isoform expression pattern was detected in the Jurkat cell line. Our data suggest a genetic interaction between MAP2K4 and HLA-DRB1, and the importance of rs10468473 and MAP2K4 splice variants in the development of autoantibody-positive RA.

[1]  Marylyn D Ritchie,et al.  Using prior knowledge and genome-wide association to identify pathways involved in multiple sclerosis , 2009, Genome Medicine.

[2]  A. Valledor,et al.  Selective Roles of MAPKs during the Macrophage Response to IFN-γ1 , 2008, The Journal of Immunology.

[3]  G. Ast,et al.  Alternative splicing and evolution: diversification, exon definition and function , 2010, Nature Reviews Genetics.

[4]  J. Scheller,et al.  The IL-6/sIL-6R complex as a novel target for therapeutic approaches , 2007, Expert opinion on therapeutic targets.

[5]  G Strandberg,et al.  Anti-CCP antibody test predicts the disease course during 3 years in early rheumatoid arthritis (the Swedish TIRA project) , 2004, Annals of the rheumatic diseases.

[6]  L. Alfredsson,et al.  Opposing effects of HLA-DRB1*13 alleles on the risk of developing anti-citrullinated protein antibody-positive and anti-citrullinated protein antibody-negative rheumatoid arthritis. , 2009, Arthritis and rheumatism.

[7]  P. Gregersen,et al.  Gene-gene and gene-environment interactions involving HLA-DRB1, PTPN22, and smoking in two subsets of rheumatoid arthritis. , 2007, American journal of human genetics.

[8]  T. Thalhamer,et al.  MAPKs and their relevance to arthritis and inflammation. , 2007, Rheumatology.

[9]  Miss A.O. Penney.  (b) , 1974, The New Yale Book of Quotations.

[10]  Lars Alfredsson,et al.  Calculating measures of biological interaction using R , 2006, European Journal of Epidemiology.

[11]  G. Firestein,et al.  “Go upstream, young man”: lessons learned from the p38 saga , 2009, Annals of the rheumatic diseases.

[12]  Lude Franke,et al.  eQTL analysis in humans. , 2009, Methods in molecular biology.

[13]  J. Smolen,et al.  Expression patterns of CD44 and CD44 splice variants in patients with rheumatoid arthritis. , 2012, Clinical and experimental rheumatology.

[14]  L. Joosten,et al.  Inflammation-dependent secretion and splicing of IL-32γ in rheumatoid arthritis , 2011, Proceedings of the National Academy of Sciences.

[15]  Peter Zenz,et al.  The rationale of pharmacoeconomic analysis in rheumatologic indications. , 2012 .

[16]  M. Liang,et al.  The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. , 1988, Arthritis and rheumatism.

[17]  The balance of expression of PTPN22 splice forms is significantly different in rheumatoid arthritis patients compared with controls , 2012, Genome Medicine.

[18]  L. Alfredsson,et al.  Gene-environment interaction between the DRB1 shared epitope and smoking in the risk of anti-citrullinated protein antibody-positive rheumatoid arthritis: all alleles are important. , 2009, Arthritis and rheumatism.

[19]  Alain Laederach,et al.  Disease-Associated Mutations That Alter the RNA Structural Ensemble , 2010, PLoS genetics.

[20]  F. Breedveld,et al.  Antibodies to citrullinated proteins and differences in clinical progression of rheumatoid arthritis , 2005, Arthritis research & therapy.

[21]  Kristel Van Steen,et al.  Travelling the world of gene-gene interactions , 2012, Briefings Bioinform..

[22]  B. Neel,et al.  TNF-stimulated MAP kinase activation mediated by a Rho family GTPase signaling pathway. , 2011, Genes & development.

[23]  G. G. Stokes.  "J." , 1890, The New Yale Book of Quotations.

[24]  Anbupalam Thalamuthu,et al.  TRAF1-C5 as a risk locus for rheumatoid arthritis--a genomewide study. , 2007, The New England journal of medicine.

[25]  E. Esplugues,et al.  Identification and characterization of a novel spliced variant that encodes human soluble tumor necrosis factor receptor 2. , 2004, International immunology.

[26]  Kristen W. Lynch,et al.  Consequences of regulated pre-mRNA splicing in the immune system , 2004, Nature Reviews Immunology.

[27]  Ryan M. Smith,et al.  mRNA Transcript Diversity Creates New Opportunities for Pharmacological Intervention , 2012, Molecular Pharmacology.

[28]  L. Alfredsson,et al.  Evidence for interaction between 5-hydroxytryptamine (serotonin) receptor 2A and MHC type II molecules in the development of rheumatoid arthritis , 2010, European Journal of Human Genetics.

[29]  L. Padyukov,et al.  Haplotypes of the interleukin‐4 receptor α chain gene associate with susceptibility to and severity of atopic asthma , 2004, Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology.

[30]  M. Wilkinson,et al.  Regulation of nonsense-mediated mRNA decay: implications for physiology and disease. , 2013, Biochimica et biophysica acta.